Identification of Novel Protein Phosphatases in the ATM Signaling Pathway
Identification of Novel Protein Phosphatases in the ATM Signaling Pathway
批准号:
8224187
负责人:
Xiongbin Lu
金额:
$4.78万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Upon DNA damage stress, the ATM kinase is rapidly phosphorylated and activated, which stimulates cell cycle arrest, cellular senescence, DNA repair, and apoptosis. When the cell is returning to its normal state following DNA repair, the ATM signaling pathway needs to be simultaneously inhibited. Very little is known about how the DNA damage response is 'deactivated' following repair. Recent evidence suggests that protein phosphatases contribute to closing the activation loop initiated by the ATM/ATR kinases to provide a homeostatic regulation. Our preliminary results showed that wildtype p53-induced phosphatase 1 (Wip1) inhibits ATM-p53 pathway by dephosphorylating several ATM targeted proteins. In particular, Wip1 stabilizes Mdm2 and MdmX by dephosphorylating their ATM phosphorylation site, resulting in decreased levels and activity of p53. If aberrantly regulated, Wip1 becomes an oncogenic phosphatase that inhibits the DNA damage response and p53 tumor suppressor pathways. We generated an expression library of human serine/threonine protein phosphatases, from which several novel phosphatases were identified as potential modulators in the ATM-p53 pathway. The hypothesis to be tested is that Wip1 and other inhibitory protein phosphatases may suppress DNA damage-induced p53 activity primarily through dephosphorylating and stabilizing Mdm2 and MdmX.
PUBLIC HEALTH RELEVANCE: Protein phosphatases remove phosphate from proteins and deactivate them, which may provide a homeostatic regulation in the DNA damage response pathway. The goal of this research project is to (1) clarify the functions of protein phosphatases in the ATM (Ataxia Telangiectasia Mutated) initiated DNA damage response pathway; (2) determine how protein phosphatases regulate DNA damage-induced p53 activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting FOXP3 mRNA splicing for breast cancer immunotherapy
-
批准号:10717185
-
项目类别:
-
资助金额:$58.52万
-
财政年份:2023
-
负责人:Xiongbin Lu
-
依托单位:
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
-
批准号:10385926
-
项目类别:
-
资助金额:$50.18万
-
财政年份:2022
-
负责人:Xiongbin Lu
-
依托单位:
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
-
批准号:10545058
-
项目类别:
-
资助金额:$49.18万
-
财政年份:2022
-
负责人:Xiongbin Lu
-
依托单位:
Identification of USP13 as a therapeutic target for ovarian cancer
-
批准号:10328885
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2018
-
负责人:Xiongbin Lu
-
依托单位:
Identification of USP13 as a therapeutic target for ovarian cancer
-
批准号:10092972
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2018
-
负责人:Xiongbin Lu
-
依托单位:
Targeting Human Cancers with Hemizygous Deletion of TP53
-
批准号:9891965
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2017
-
负责人:Xiongbin Lu
-
依托单位:
Targeting HER2-low breast cancer with 17p loss
-
批准号:10203209
-
项目类别:
-
资助金额:$53.54万
-
财政年份:2016
-
负责人:Xiongbin Lu
-
依托单位:
Targeting HER2-low breast cancer with 17p loss
-
批准号:10615742
-
项目类别:
-
资助金额:$52.47万
-
财政年份:2016
-
负责人:Xiongbin Lu
-
依托单位:
Targeting HER2-low breast cancer with 17p loss
-
批准号:10399601
-
项目类别:
-
资助金额:$52.47万
-
财政年份:2016
-
负责人:Xiongbin Lu
-
依托单位:
Targeting Human Cancers with Hemizygous Deletion of TP53
-
批准号:9074698
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2016
-
负责人:Xiongbin Lu
-
依托单位:
Ubiquitin specific peptidases as redox sensor in oncogene-induced p53 signaling
-
批准号:9015747
-
项目类别:
-
资助金额:$0.61万
-
财政年份:2015
-
负责人:Xiongbin Lu
-
依托单位:
ROLE OF PROTEIN PHOSPHATASES IN THE DNA DAMAGE RESPONSE
-
批准号:8360353
-
项目类别:
-
资助金额:$3.54万
-
财政年份:2011
-
负责人:Xiongbin Lu
-
依托单位:
ROLE OF PROTEIN PHOSPHATASES IN THE DNA DAMAGE RESPONSE
-
批准号:8167873
-
项目类别:
-
资助金额:$14.22万
-
财政年份:2010
-
负责人:Xiongbin Lu
-
依托单位:
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas
-
批准号:8230806
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
Identification of Novel Protein Phosphatases in the ATM Signaling Pathway
-
批准号:7762036
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas
-
批准号:7660999
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas
-
批准号:8038452
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
Identification of Novel Protein Phosphatases in the ATM Signaling Pathway
-
批准号:7941711
-
项目类别:
-
资助金额:$2.59万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas
-
批准号:8444681
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2009
-
负责人:Xiongbin Lu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: